Alphabet’s (NASDAQ:GOOGL) unit, Google, will reportedly allow promotions for certain pharmaceuticals containing cannabidiol (CBD) and topical, hemp-derived products with tetrahydrocannabinol content less than 0.3% on its platform beginning January 20, 2023.
Advertisements of these products have long been restricted on several digital platforms, despite the passage of the 2018 Farm Bill, which legalized them in the U.S.
As of now, the eligible ads will be shown to users above the age of 18 in California, Colorado, and Puerto Rico. Also, these ads will not be reflected as masthead YouTube banners.
It is worth mentioning that the tech giant reported a 3.2% sequential drop in revenue from the advertising business in its third-quarter results. The decline was due to lower advertisement spending on YouTube and the Google Network as lower engagement levels were witnessed in gaming.
Is GOOGL a Good Buy?
Alphabet stock has a Strong Buy consensus rating based on 29 unanimous Buys. The average stock price target of $125.76 suggests about 40.9% upside potential from current levels. Shares have declined 38.5% year-to-date.
GOOGL is one of Wall Street’s favorite picks. Moreover, as per TipRanks’ Smart Score rating, GOOGL stock has a Smart Score of 10, implying that the company is highly likely to outperform market expectations.
Disclosure